Cargando…

Making Sense in Antisense: Therapeutic Potential of Noncoding RNAs in Diabetes-Induced Vascular Dysfunction

The rapid rise of type II diabetes mellitus and its accompanying vascular complications call for novel approaches in unravelling its pathophysiological mechanisms and designing new treatment modalities. Noncoding RNAs represent a class of previously unknown molecular modulators of this disease. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eken, Suzanne M., Jin, Hong, Chernogubova, Ekaterina, Maegdefessel, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863503/ https://www.ncbi.nlm.nih.gov/pubmed/24369540 http://dx.doi.org/10.1155/2013/834727

Ejemplares similares

Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma
por: Mosca, Nicola, et al.
Publicado: (2023)

miR-29b Mediates the Chronic Inflammatory Response in Radiotherapy-Induced Vascular Disease
por: Eken, Suzanne M., et al.
Publicado: (2019)

Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
por: Gagliardi, Maria, et al.
Publicado: (2022)

An effort to make sense of antisense transcription in bacteria
por: Lasa, Iñigo, et al.
Publicado: (2012)

Why antisense could make sense for neurodegeneration
por: Massey, T. H., et al.
Publicado: (2017)

Targeting non-coding RNAs for novel treatment strategies in vascular diseases
por: Winter, Hanna, et al.
Publicado: (2023)

Long noncoding RNAs in key cellular processes involved in aortic aneurysms
por: Wu, Zhi-yuan, et al.
Publicado: (2020)

Characterization of plastid psbT sense and antisense RNAs
por: Zghidi-Abouzid, Ouafa, et al.
Publicado: (2011)

Identification of antisense long noncoding RNAs that function as SINEUPs in human cells
por: Schein, Aleks, et al.
Publicado: (2016)

Antisense technology for cancer therapy: does it make sense?
por: Carter, G., et al.
Publicado: (1993)

Erratum: miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development
por: Maegdefessel, Lars, et al.
Publicado: (2015)

Noncoding RNAs in Vascular Aging
por: Cao, Qidong, et al.
Publicado: (2020)

Natural Antisense Makes Sense for Gene-specific Activation in Brain
por: Varela, Miguel A, et al.
Publicado: (2012)

Aneurysm miRNA Signature Differs, Depending on Disease Localization and Morphology
por: Busch, Albert, et al.
Publicado: (2016)

Trans-natural antisense transcripts including noncoding RNAs in 10 species: implications for expression regulation
por: Li, Jiong-Tang, et al.
Publicado: (2008)

The Roles of Antisense Long Noncoding RNAs in Tumorigenesis and Development through Cis-Regulation of Neighbouring Genes
por: Jiang, Binyuan, et al.
Publicado: (2023)

Antisense RNAs Influence Promoter Usage of Their Counterpart Sense Genes in Cancer
por: Bellido Molias, Fernando, et al.
Publicado: (2021)

Noncoding RNAs in Vascular Cell Biology and Restenosis
por: Efovi, Denis, et al.
Publicado: (2022)

Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential
por: Lin, Hongze, et al.
Publicado: (2023)

Antisense Translates into Sense
por: Peltz, Stuart W., et al.
Publicado: (1999)

The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma
por: Joshi, Piyush, et al.
Publicado: (2019)

Making Sense out of Antisense Transcription in Human T-Cell Lymphotropic Viruses (HTLVs)
por: Barbeau, Benoit, et al.
Publicado: (2011)

Long Noncoding RNA MIAT Controls Advanced Atherosclerotic Lesion Formation and Plaque Destabilization
por: Fasolo, Francesca, et al.
Publicado: (2021)

Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease
por: Kato, Mitsuo
Publicado: (2018)

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
por: Bajan, Sarah, et al.
Publicado: (2020)

The Role of MicroRNA-21 in Venous Neointimal Hyperplasia: Implications for Targeting miR-21 for VNH Treatment
por: Kilari, Sreenivasulu, et al.
Publicado: (2019)

Targeting long non-coding RNA NUDT6 enhances smooth muscle cell survival and limits vascular disease progression
por: Winter, Hanna, et al.
Publicado: (2023)

Long noncoding RNAs in vascular smooth muscle cells regulate vascular calcification
por: Jeong, Geon, et al.
Publicado: (2019)

Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets
por: Min, Li, et al.
Publicado: (2017)

Regulation of CCL2 expression in human vascular endothelial cells by a neighboring divergently transcribed long noncoding RNA
por: Khyzha, Nadiya, et al.
Publicado: (2019)

The long noncoding RNA CHROME regulates cholesterol homeostasis in primate
por: Hennessy, Elizabeth J., et al.
Publicado: (2018)

Involvement of Myeloid Cells and Noncoding RNA in Abdominal Aortic Aneurysm Disease
por: Knappich, Christoph, et al.
Publicado: (2020)

Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets
por: Fatima, Roshan, et al.
Publicado: (2015)

Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Renal Fibrosis
por: Jung, Hyun Jin, et al.
Publicado: (2020)

Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications
por: Shahzad, Uswa, et al.
Publicado: (2021)

Noncoding RNAs in subchondral bone osteoclast function and their therapeutic potential for osteoarthritis
por: Duan, Li, et al.
Publicado: (2020)

Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Organ Transplantation
por: Salehi, Saeedeh, et al.
Publicado: (2022)

Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications
por: Leti, Fatjon, et al.
Publicado: (2017)

Noncoding RNAs Are Promising Therapeutic Targets for Diabetic Retinopathy: An Updated Review (2017–2022)
por: Wang, Mengchen, et al.
Publicado: (2022)

Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer
por: Son, Seung Wan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pdais038cvu9nft460qilh3ue4